Gancitano, G. et al. 2018. Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer. Farmeconomia. Health economics and therapeutic pathways. 19, 1 (May 2018). DOI:https://doi.org/10.7175/fe.v19i1.1354.